126
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

High-intensity focused ultrasound versus transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis

, , ORCID Icon, , &
Pages 1879-1889 | Received 17 Sep 2022, Accepted 12 Jun 2023, Published online: 31 Jul 2023

References

  • Bao M, Li XS. 2008. Percutaneous high intensity focused ultrasound therapy for primary liver cancer. Chin J Gastroenterol Hepatol. 17:353–354.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, et al. 2013. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol. 19(20):3083–3089.
  • Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, Dai WC, Chan AC, Chan SC, Yau TC, et al. 2013. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford). 15(8):567–573.
  • Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, et al. 2014. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas. Liver Int. 34(6):e136–e143.
  • Cho SH, Sung HY, Han JY, Jung SE, Han ST, Lee YS, Song JH. 2011. Therapeutic efficacy of high intensity focused ultrasound in advanced hepatocellular carcinoma. Hepatology. 54:1386A–1387A.
  • Diana M, Schiraldi L, Liu YY, Memeo R, Mutter D, Pessaux P, Marescaux J. 2016. High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives. Hepatobiliary Surg Nutr. 5(4):329–344.
  • Facciorusso A, Barone M. 2016. Thermal ablative treatments for hepatocellular carcinoma. In: Hepatocellular carcinoma. Cham (Switzerland): Springer. p. 453–466.
  • Huang Y, Zhang WX, Peng HD, Wei YH. 2010. Effect of HIFU and TACE on immune function in patients with primary liver cancer. Zhejiang Clin Med J. 12:337–339.
  • Ji Y, Zhu J, Zhu L, Zhu Y, Zhao H. 2020. High-intensity focused ultrasound ablation for unresectable primary and metastatic liver cancer: real-world research in a Chinese tertiary center with 275 cases. Front Oncol. 10:519164.
  • Jiang BL, Gao X, Xiong J, Zhu PY, Luo Y, Xu D, Tang Y, Wang YT, Chen C, Yang HY, et al. 2020. Experimental study on synergistic effect of HIFU treatment of tumors using Bifidobacterium bound with cationic phase-change nanoparticles. Eur Rev Med Pharmacol Sci. 24(10):5714–5725.
  • Li J, Guo WZ, Zhao YF, Wu Y, Zhang SJ. 2019. High intensity focused ultrasound, cryoablation with argon helium knife and radiofrequency ablation for small liver cancer. Chin J Hepatol Surg (Electronic Edition). 8:133–138.
  • Lin L, Yan L, Liu Y, Qu C, Ni J, Li H. 2020. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017. Liver Cancer. 9(5):563–582.
  • Litière S, Isaac G, De Vries EGE, Bogaerts J, Chen A, Dancey J, Ford R, Gwyther S, Hoekstra O, Huang E, et al. 2019. RECIST 1.1 for response evaluation apply not only to chemotherapy-treated patients but also to targeted cancer agents: a pooled database analysis. J Clin Oncol. 37(13):1102–1110.
  • Liu YE, Zong J, Ren XC, Lin Q. 2019. High-intensity focused ultrasound combined with transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma: a case report. Medicine (Baltimore). 98(31):e16660.
  • Luo J, Ren X, Yu T. 2015. Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: an evaluation based on controlled trials in China. Int J Radiat Biol. 91(6):480–485.
  • Ma QJ, Wang Q. 2006. Role and evaluation of local ablation in the treatment of small hepatic space occupying lesions. Chin J Pract Surg. 26:693–695.
  • Martin AN, Wilkins LR, Das D, Johnston LE, Bauer TW, Adams RB, Zaydfudim VM. 2019. Efficacy of radiofrequency ablation versus transarterial chemoembolization for patients with solitary hepatocellular carcinoma ≤3 cm. Am Surg. 85(2):150–155.
  • McCarty TR, Farrelly J, Njei B, Jamidar P, Muniraj T. 2021. Role of prophylactic cholecystectomy after endoscopic sphincterotomy for biliary stone disease: a systematic review and meta-analysis. Ann Surg. 273(4):667–675.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097.
  • Oh JH, Sinn DH, Choi GS, Kim JM, Joh JW, Kang TW, Hyun D, Kang W, Gwak GY, Paik YH, et al. 2020. Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria. Ann Surg Treat Res. 99(4):238–246.
  • Paiella S, De Pastena M, D'Onofrio M, Crinò SF, Pan TL, De Robertis R, Elio G, Martone E, Bassi C, Salvia R. 2018. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation. Transl Gastroenterol Hepatol. 3:80.
  • Peng HD. 2008. The influence of treatment of high intensity focused ultrasound for primary hepatic carcinoma upon immune state and its clinical meaning. Zhanjiang, Guangdong (China): Guangdong Medical College. p. 1–73.
  • Qiao W, Yu Y, Huang Y, Gao W, Liu Z. 2020. Impact of focused ultrasound on the ethanol ablation of VX2 liver tumours in rabbits. Eur Radiol. 30(11):5862–5870.
  • Qin LX. 2003. Application of local ablation in the treatment of small liver cancer and its comparison with surgical operation. J Clin Res. 20:652–657.
  • Rauch M, Marinova M, Schild HH, Strunk H. 2015. High intensity focused ultrasound for the treatment of advanced liver cancer. Dig Liver Dis. 47(11):989–990.
  • Ren R, Li QG, Du CY. 2010. Analysis of clinical efficacy of interventional chemoembolization combined with high intensity focused ultrasound in the treatment of primary liver cancer. J Pract Med. 26:4164–4166.
  • Sadeghi-Goughari M, Jeon S, Kwon HJ. 2020. Magnetic nanoparticles-enhanced focused ultrasound heating: size effect, mechanism, and performance analysis. Nanotechnology. 31(24):245101.
  • She WH, Cheung TT, Jenkins CR, Irwin MG. 2016. Clinical applications of high-intensity focused ultrasound. Hong Kong Med J. 22(4):382–392.
  • Stang A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25(9):603–605.
  • van den Bijgaart RJ, Eikelenboom DC, Hoogenboom M, Fütterer JJ, den Brok MH, Adema GJ. 2017. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 66(2):247–258.
  • Wu Y, Li J, Zhang SJ, Zhao YF, Zhao LS, Ma XX, Feng LS, Fan ZJ. 2012. Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. Chin J Surg. 50(8):691–694.
  • Xiao WB, Liu H. 2015. Comparison of the short-term effects of radiofrequency ablation and high intensity focused ultrasound in the treatment of large primary liver cancer. J Ultrasound Clin Med. 17:252–254.
  • Xu LJ. 2014. Clinical application of high intensity focused ultrasound therapy for primary liver cancer with vascular invasion. Chongqing (China): Chongqing Medical University. p. 1–54.
  • Xue J. 2013. Clinical study of high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of advanced primary liver cancer. J Mod Dig Intervent. 18:102–105.
  • Yang J, Zhang XL, Zhou YS. 2014. Value of contrast-enhanced ultrasonography in evaluating curative effect of TACE combined with HIFU for treating hepatocellular carcinoma. J Ultrasound Clin Med. 16:123–125.
  • Yang HJ, Lee JH, Lee DH, Yu SJ, Kim YJ, Yoon JH, Kim HC, Lee JM, Chung JW, Yi NJ, et al. 2014. Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. Radiology. 271(3):909–918.
  • Zhang L, Wong FWS. 2020. A high-intensity focused ultrasound surgery theater design in a private clinic. Gynecol Minim Invasive Ther. 9(1):1–5.
  • Zhang Q, Bian SQ, Lv W, Kou D, Hu HL, Guo SS, Cao ZS. 2019. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer. Eur Rev Med Pharmacol Sci. 23(3 Suppl):239–246.
  • Zhang ZS. 2011. The analysis of different interventional therapy in 123 liver cancer patients. Chongqing Med J. 40:3382–3383.
  • Zhao S, Dou W, Fan Q, Hu J, Li H, Zhang X, Zhang Q, Liu L. 2020. Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma. Ann Transl Med. 8(9):587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.